Search Within

Thoracic Oncology

Formats
  1. Meeting Abstract (1709)
  2. Journal Article (1439)
  3. Review (82)
  4. Editorial (58)
  5. Book Section (35)
  6. Guidelines (25)
  7. Conference Paper (21)
  8. Correspondence (10)
  9. Research Letter (7)
  10. Miscellaneous (6)
  11. Book Whole (2)
Groups
  1. Department of Medicine (3394)
  2. Solid Tumor Oncology Division (3394)
  3. GSK Faculty (1071)
  4. Department of Pathology and Laboratory Medicine (809)
  5. Center for Molecular Imaging and Biotechnology (CMIB) (662)
  6. Human Oncology and Pathogenesis Program (635)

More Groups

People
  1. Mark Kris (872)
  2. Alexander Drilon (637)
  3. Gregory Riely (605)
  4. Charles Rudin (495)
  5. Marc Ladanyi (418)
  6. Matthew Hellmann (412)

More People

Years
  1. 2025 (114)
  2. 2024 (271)
  3. 2023 (273)
  4. 2022 (337)
  5. 2021 (337)
  6. 2020 (258)

More Years

Publications
  1. Journal of Clinical Oncology (703)
  2. Journal of Thoracic Oncology (517)
  3. Annals of Oncology (278)
  4. Clinical Cancer Research (158)
  5. Cancer Research (128)
  6. International Journal of Radiation Oncology, Biology, Physics (89)

More Publications

Publishers
  1. American Society of Clinical Oncology (782)
  2. Elsevier Inc. (738)
  3. American Association for Cancer Research (386)
  4. Oxford University Press (352)
  5. Nature Publishing Group (156)
  6. Elsevier Science, Inc. (79)

More Publishers

Results (3394)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Phase Ib study of atezolizumab combined with cobimetinib in patients with solid tumors
    Journal Article

    Hellmann, M. D.; Kim, T. W.; Lee, C. B.; Goh, B. C.; Miller, W. H. Jr; Oh, D. Y.; Jamal, R.; Chee, C. E.; Chow, L. Q. M.; Gainor, J. F.; more...
    Annals of Oncology (2019)

    Fulltext@MSK | Save
  • Concurrent RB1 and TP53 alterations define a subset of EGFR-mutant lung cancers at risk for histologic transformation and inferior clinical outcomes
    Journal Article

    Offin, M.; Chan, J. M.; Tenet, M.; Rizvi, H. A.; Shen, R.; Riely, G. J.; Rekhtman, N.; Daneshbod, Y.; Quintanal-Villalonga, A.; Penson, A.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Positron-emission tomographic imaging of a fluorine 18-radiolabeled Poly(ADP-ribose) polymerase 1 inhibitor monitors the therapeutic efficacy of talazoparib in SCLC patient-derived xenografts
    Journal Article

    Laird, J.; Lok, B. H.; Carney, B.; Kossatz, S.; de Stanchina, E.; Reiner, T.; Poirier, J. T.; Rudin, C. M.
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Mesothelioma: Scientific clues for prevention, diagnosis, and therapy
    Review

    Carbone, M.; Adusumilli, P. S.; Alexander, H. R. Jr; Baas, P.; Bardelli, F.; Bononi, A.; Bueno, R.; Felley-Bosco, E.; Galateau-Salle, F.; Jablons, D.; more...
    CA - A Cancer Journal for Clinicians (2019)

    Fulltext@MSK | Save
  • Optimizing the sequencing of tyrosine kinase inhibitors (TKIs) in epidermal growth factor receptor (EGFR) mutation-positive non-small cell lung cancer (NSCLC)
    Review

    Gelatti, A. C. Z.; Drilon, A.; Santini, F. C.
    Lung Cancer (2019)

    Fulltext@MSK | Save
  • Clinical activity, tolerability, and long-term follow-up of durvalumab in patients with advanced NSCLC
    Journal Article

    Antonia, S. J.; Balmanoukian, A.; Brahmer, J.; Ou, S. H. I.; Hellmann, M. D.; Kim, S. W.; Ahn, M. J.; Kim, D. W.; Gutierrez, M.; Liu, S. V.; more...
    Journal of Thoracic Oncology (2019)

    Fulltext@MSK | Save
  • Systemic therapy for locally advanced and metastatic non-small cell lung cancer: A review
    Review

    Arbour, K. C.; Riely, G. J.
    JAMA - Journal of the American Medical Association (2019)

    Fulltext@MSK | Save
  • Nivo-lution in mesothelioma
    Editorial

    Mansfield, A. S.; Zauderer, M. G.
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • Genomic correlates of disease progression and treatment response in prospectively characterized gliomas
    Journal Article

    Jonsson, P.; Lin, A. L.; Young, R. J.; DiStefano, N. M.; Hyman, D. M.; Li, B. T.; Berger, M. F.; Zehir, A.; Ladanyi, M.; Solit, D. B.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save
  • A phase Ib/II study of ramucirumab in combination with emibetuzumab in patients with advanced cancer
    Journal Article

    Harding, J. J.; Zhu, A. X.; Bauer, T. M.; Choueiri, T. K.; Drilon, A.; Voss, M. H.; Fuchs, C. S.; Abou-Alfa, G. K.; Wijayawardana, S. R.; Wang, X. A.; more...
    Clinical Cancer Research (2019)

    Fulltext@MSK | Save